Managing Class II Furcation Defects with Propolis
Clinical and Radiographic Outcomes of Class II Furcation Defects Management Using Propolis: A Case Series
This study is testing if propolis, a natural substance, can help treat gum issues in lower molars for patients with specific periodontal health needs.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Enrollment | 10 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo, El-Manial) |
| Trial ID | NCT06060340 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of propolis in managing class II furcation defects in lower molars. It involves a case series approach where patients with specific periodontal health criteria will receive treatment using propolis, a natural substance known for its regenerative properties. The study aims to assess both clinical and radiographic outcomes to determine the potential benefits of this cost-effective therapy. By focusing on a natural product, the research seeks to provide an alternative to more expensive graft materials and surgical interventions.
Who should consider this trial
Good fit: Ideal candidates include systemically healthy individuals with lower molars exhibiting class II furcation defects and good periodontal health.
Not a fit: Patients who smoke, are pregnant or lactating, or have advanced periodontitis may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could offer a cost-effective and natural alternative for managing furcation defects, improving patient outcomes.
How similar studies have performed: While the use of propolis in dental treatments is promising, this specific application for furcation defects is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Inclusion criteria: 1. Lower molars with class II furcation defects. 2. Full mouth plaque score (FMPS )\<20% at baseline. 3. Full mouth bleeding score (FMBS )\<10% at baseline. 4. Systemically healthy. 5. Cooperative patients. Exclusion Criteria: * Exclusion criteria: 1. Smokers. 2. Pregnancy and lactation. 3. Stage 4 Grade C periodontitis.
Where this trial is running
Cairo, El-Manial
- Cairo university — Cairo, El-Manial, Egypt (Recruiting)
Study contacts
- Study coordinator: Ahmed Said Allam, BDs
- Email: ahmed.allam@dentistry.cu.edu.eg
- Phone: 01093929125
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.